(BNS) Bank of Nova Scotia - Ratings and Ratios
Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA0641491075
BNS: Banking, Investments, Mortgages, Loans, Insurance, Credit Cards
Bank of Nova Scotia, or Scotiabank, is a Canadian banking titan with operations spanning Canada, the U.S., Mexico, Peru, Chile, Colombia, the Caribbean, Central America, and beyond. This geographic diversity is a strategic strength, allowing the bank to navigate different economic cycles and tap into high-growth markets.
Scotiabanks business is divided into four main segments: Canadian Banking, International Banking, Global Wealth Management, and Global Banking and Markets. This structure allows the bank to cater to a wide range of clients, from individual consumers to large corporations, offering everything from basic chequing accounts to complex trade finance solutions.
For individual customers, Scotiabank provides the essentials: debit and credit cards, savings accounts, mortgages, loans, and insurance. But they also go beyond the basics, offering investment products like mutual funds, ETFs, and other wealth management services. Their approach to wealth management is particularly noteworthy, with a range of services that include online brokerage, trust services, and private banking.
On the business side, Scotiabank serves small, medium, and large businesses with lending, deposit, cash management, and trade finance solutions. This makes them a one-stop shop for businesses looking to manage their finances effectively. Their expertise in trade finance is especially valuable for companies operating across borders.
Founded in 1832 and headquartered in Toronto, Scotiabank has a long history of stability and growth. With a market cap of over $101 billion CAD, the bank is a major player in the financial industry. Its P/E ratio of 12.80 and forward P/E of 10.71 suggest that investors have confidence in its ability to generate future earnings.
Scotiabanks international presence is a key part of its strategy. By operating in both developed and emerging markets, the bank can balance stability with growth opportunities. This diversification helps mitigate risks and positions the bank well for long-term success.
Additional Sources for BNS Stock
BNS Stock Overview
Market Cap in USD | 69,696m |
Sector | Financial Services |
Industry | Banks - Diversified |
GiC Sub-Industry | Diversified Banks |
IPO / Inception |
BNS Stock Ratings
Growth 5y | 44.6% |
Fundamental | 12.0% |
Dividend | 68.6% |
Rel. Strength Industry | -8.03 |
Analysts | - |
Fair Price Momentum | 70.12 CAD |
Fair Price DCF | 251.46 CAD |
BNS Dividends
Dividend Yield 12m | 6.08% |
Yield on Cost 5y | 8.17% |
Annual Growth 5y | 3.33% |
Payout Consistency | 89.1% |
BNS Growth Ratios
Growth Correlation 3m | -91.4% |
Growth Correlation 12m | 77.2% |
Growth Correlation 5y | 52% |
CAGR 5y | 6.74% |
CAGR/Max DD 5y | 0.19 |
Sharpe Ratio 12m | 0.99 |
Alpha | 7.66 |
Beta | 0.45 |
Volatility | 15.84% |
Current Volume | 4005.6k |
Average Volume 20d | 3625k |
As of February 22, 2025, the stock is trading at CAD 71.89 with a total of 4,005,584 shares traded.
Over the past week, the price has changed by -0.96%, over one month by -3.30%, over three months by -7.14% and over the past year by +19.59%.
Neither. Based on ValueRay Fundamental Analyses, Bank of Nova Scotia is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 11.95 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BNS as of February 2025 is 70.12. This means that BNS is currently overvalued and has a potential downside of -2.46%.
Bank of Nova Scotia has no consensus analysts rating.
According to ValueRays Forecast Model, BNS Bank of Nova Scotia will be worth about 76.2 in February 2026. The stock is currently trading at 71.89. This means that the stock has a potential upside of +6.04%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 81.3 | 13.1% |
Analysts Target Price | - | - |
ValueRay Target Price | 76.2 | 6% |